Pectoral nerve block versus thoracic paravertebral block to prevent chronic pain after mastectomy
Official title: Pectoral Nerve Block Versus Paravertebral Block In The Incidence of Chronic Pain After Breast Cancer Surgery: A Randomized Clinical Trial
Run by Assiut University · NCT06082206 · Data updated 2026-11-12
This trial will test whether a pectoral (PECS) block or a thoracic paravertebral (TPVB) block given during mastectomy better prevents long-term chest, axillary, or arm pain in adult women.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 65 Years |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Status | Recruiting |
| Started | November 15, 2023 |
| Main results expected | August 2026 |
| Study ends | August 2026 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT06082206 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 20–65 years with BMI 25–35 and ASA I–III who are scheduled for unilateral mastectomy (with or without axillary node dissection) are ideal candidates.
✕Probably not a fit
Men, pregnant or breastfeeding women, patients with active malignant disease, bilateral or recent ipsilateral breast surgery, life expectancy under two years, or those outside the stated age/BMI/health criteria would not be eligible and are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adult women undergoing mastectomy under general anesthesia receive either an ultrasound-guided thoracic paravertebral block (TPVB) or pectoral nerve blocks (PEC I/II) in addition to standard postoperative analgesia, and their pain, shoulder function, and complications are followed after surgery. The trial enrolls patients aged 20–65 with BMI 25–35 and ASA I–III who are having unilateral mastectomy with or without axillary lymph node or sentinel node dissection. Ultrasound guidance is used to increase block accuracy and reduce complications, and outcomes include incidence of chronic post-mastectomy pain as well as acute analgesic effectiveness and adverse events. Follow-up includes postoperative pain assessments and longer-term evaluation for development of chronic pain.
Why it matters
Potential benefit: If one block proves superior, patients could have lower rates of chronic post-mastectomy pain, faster recovery, and reduced opioid use.
How similar studies have gone: Previous trials show both TPVB and PECS blocks reduce acute postoperative pain after breast surgery, but evidence is mixed about which approach better prevents chronic post-mastectomy pain.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA grade I, II, or III female patients in the age group of 20-65 years * with body mass index (BMI) of 25-35 who were undergoing mastectomy with or without axillary lymph node or sentinel lymph node dissection or partial mastectomy (sparing the skin, areola, and nipple) with axillary lymph node dissection Exclusion Criteria: * male sex; patient refusal, * a life expectancy less than 2 yr; * active malignant disease; pregnant or breastfeeding women; * bilateral surgery; ipsilateral breast surgery in the past 3 yr;
Where it's running
-
Assiut governorate
Asyut, Egypt Recruiting
Study contacts
- Study coordinator: Ghada Abo Elfadl
- Email: ghadafadl77@gmail.com
- Phone: 01005802086
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
-
Comparing dexmedetomidine and lidocaine for pain management after mastectomy
This study is testing whether dexmedetomidine or lidocaine works better for managing pain after mastectomy surgery in adults aged 18 to 75.
-
Comparing two nerve-block options to reduce pain after total mastectomy.
This test tries whether a PECS-II block given before surgery or a pectoral block given during surgery, using bupivacaine or liposomal bupivacaine, provides better pain control after total mastectomy for breast cancer or high-risk patients.
-
Bionic breast implant to restore touch and reduce chronic pain after mastectomy
This project will try a bionic breast implant that stimulates nerves to restore touch and reduce chronic pain for adults having bilateral mastectomy with two-stage (tissue expander) reconstruction.
-
Upfront treatment for breast cancer with nodal metastases
This study is testing if starting treatment with surgery and targeted therapy can help women with early-stage breast cancer that has spread to their lymph nodes live longer and have fewer recurrences.
-
Erector spinae plane block for managing pain after breast cancer surgery
This study is testing if a special nerve block combined with a medication can help reduce pain and improve recovery for women after breast cancer surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.